Moyamoya disease is progressive. The narrowing of the internal carotid arteries does not reverse on its own, and no medication can halt or slow it. Without surgical intervention, the natural history is one of increasing cerebral ischemia, recurrent strokes, and — in adults — a growing risk of hemorrhage from the fragile collateral vessels the brain has built to compensate.
Surgery works by creating new pathways for blood to reach the brain, bypassing the narrowed arteries entirely. The goal is not to open the blocked vessels — that is not possible in moyamoya — but to provide the brain with an alternative blood supply that is durable, adequate, and not prone to rupture.
The evidence is clear: surgical revascularization reduces the risk of subsequent stroke and, in many patients — particularly children — leads to measurable neurological improvement over the months and years that follow.
Medical management
Medications play a supporting role but cannot substitute for surgery. The standard medical regimen includes aspirin to reduce the risk of clot formation in the narrowed vessels, and — where indicated — anticonvulsants for seizure prevention. Calcium channel blockers are sometimes used for headache management, though they must be used cautiously because they can lower blood pressure and potentially worsen cerebral ischemia.
Medical management alone is typically reserved for patients who are not surgical candidates, or as a bridge while surgery is being planned. It does not alter the underlying disease course.
Direct revascularization
STA-MCA bypass
The most established direct technique is the superficial temporal artery to middle cerebral artery (STA-MCA) bypass. In this procedure, the superficial temporal artery — a branch of the external carotid that runs along the temple beneath the skin — is disconnected from its normal course and microsurgically sutured directly to a cortical branch of the middle cerebral artery on the brain surface.
The result is immediate: blood flows from the external carotid system into the brain through the new connection, bypassing the narrowed internal carotid entirely. This provides an immediate increase in cerebral blood flow to the affected territory.
Direct bypass is generally preferred in adults, where the recipient cortical vessels are large enough to accept a direct anastomosis and where the immediate flow augmentation is most needed. In children, the cortical vessels are often too small for a reliable direct connection, which is why indirect techniques are frequently chosen instead — or combined with a direct bypass in a hybrid approach.
The STA-MCA bypass is not unique to moyamoya. It is also used for atherosclerotic cerebrovascular disease and as part of the treatment for certain complex aneurysms. Dr. Aghayev's experience with the technique spans multiple indications. Read more about STA-MCA bypass as a standalone procedure →
Indirect revascularization
Indirect techniques take a different approach: instead of creating an immediate surgical connection between two vessels, they place blood-supply-rich tissue directly against the brain surface and allow new blood vessels to grow naturally over a period of weeks to months. This process — called neoangiogenesis — exploits the brain's own response to ischemia.
EDAS (Encephaloduroarteriosynangiosis)
In EDAS, the superficial temporal artery is dissected free from the scalp and laid directly on the surface of the brain. Over time, new vessels sprout from the artery into the underlying brain tissue, gradually establishing a new blood supply. The advantage of EDAS is its relative simplicity and lower technical demand compared to direct bypass; the disadvantage is the delay — meaningful revascularization takes 3–6 months to develop.
Pial synangiosis
A variation of EDAS in which the arachnoid membrane of the brain is opened and the donor tissue is placed directly against the pial surface, maximizing contact and encouraging faster vessel ingrowth. This technique is particularly well-suited to children.
Other indirect approaches
Several other indirect techniques exist, including EMS (encephalomyosynangiosis), in which a portion of the temporalis muscle is placed on the brain surface, and EDAMS, which combines elements of both EDAS and EMS. The choice of indirect technique depends on the surgeon's training and the specific anatomy of the patient.
Choosing an approach
The decision between direct, indirect, and combined revascularization depends on several factors:
- Patient age — children often receive indirect or combined approaches due to small vessel caliber; adults more commonly receive direct bypass
- Disease severity and Suzuki stage — more advanced disease may benefit from combined approaches that provide both immediate and long-term flow augmentation
- Hemisphere involvement — bilateral moyamoya often requires staged surgeries, one hemisphere at a time
- Surgeon experience — direct bypass demands microsurgical expertise that not all cerebrovascular surgeons possess; indirect techniques have a lower technical threshold but still require careful planning
- Presentation — hemorrhagic presentations in adults may warrant more aggressive direct revascularization
In many cases, a combined approach — direct bypass supplemented by indirect revascularization — offers the best of both worlds: immediate flow augmentation from the bypass plus long-term collateral development from the indirect component.
Recovery
The immediate postoperative period requires careful blood pressure management to avoid both hypo- and hypertension, either of which can compromise the new bypass. Most patients spend 1–2 days in intensive care monitoring, followed by several days on a standard ward. Hospital stays typically range from 5 to 10 days.
Return to normal activities varies: desk work within 3–4 weeks, physical activity within 6–8 weeks. For indirect revascularization, meaningful improvement in cerebral blood flow becomes evident on follow-up imaging at 3–6 months. For direct bypass, flow improvement is immediate but the full benefit — including collateral maturation around the anastomosis — develops over a similar timeframe.
Long-term follow-up is essential. Moyamoya is a bilateral disease in most patients, and the untreated hemisphere may require surgery in the future. Annual imaging surveillance is standard practice. Read about long-term prognosis and outcomes →
Dr. Kamran Aghayev, MD
Associate Professor of Neurosurgery. Fellowship-trained at the H. Lee Moffitt Cancer Center, University of South Florida. Over 20 years of operative experience in cerebrovascular and complex brain conditions.